MENU
ACRV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Acrivon Therapeutics (ACRV) Ownership - Who owns Acrivon Therapeutics?

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform... Show more

Profile

Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 207-8979
Employees
61
Web
https://www.acrivon.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
71.72M
P/E Ratio
N/A
Total Cash
137.42M
Projected Growth
N/A
Total Debt
3.26M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
4.37
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

ACRV
Capitalization
71.7M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
137M
Total Cash/Share
4.37
Total Debt
3.26M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
143M
P/B Ratio
0.50
Cash Flow
N/A
Earnings
-2.24
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
31K
Current Ratio
10.31
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-93.21M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-44.18
Shares Held By Institutions
22.5M
Shares Outstanding - Current
31.5M
Total Liabilities
15.5M
Total Volume MTD
N/A
Value
1
Gain YTD
-62.126
View a ticker or compare two or three
ACRV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 207-8979
Employees
61
Web
https://www.acrivon.com